AU2002239395A1 - Hiv treatment with benzimidazoles - Google Patents

Hiv treatment with benzimidazoles

Info

Publication number
AU2002239395A1
AU2002239395A1 AU2002239395A AU3939502A AU2002239395A1 AU 2002239395 A1 AU2002239395 A1 AU 2002239395A1 AU 2002239395 A AU2002239395 A AU 2002239395A AU 3939502 A AU3939502 A AU 3939502A AU 2002239395 A1 AU2002239395 A1 AU 2002239395A1
Authority
AU
Australia
Prior art keywords
benzimidazoles
hiv treatment
hiv
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002239395A
Inventor
James Berger Camden
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of AU2002239395A1 publication Critical patent/AU2002239395A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
AU2002239395A 2000-11-01 2001-10-31 Hiv treatment with benzimidazoles Abandoned AU2002239395A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US70395500A 2000-11-01 2000-11-01
US09/703,955 2000-11-01
PCT/US2001/045019 WO2002041891A2 (en) 2000-11-01 2001-10-31 Hiv treatment with benzimidazoles

Publications (1)

Publication Number Publication Date
AU2002239395A1 true AU2002239395A1 (en) 2002-06-03

Family

ID=24827464

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002239395A Abandoned AU2002239395A1 (en) 2000-11-01 2001-10-31 Hiv treatment with benzimidazoles

Country Status (3)

Country Link
US (2) US20030149088A1 (en)
AU (1) AU2002239395A1 (en)
WO (1) WO2002041891A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6506783B1 (en) * 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
US6462062B1 (en) * 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6608096B1 (en) 2000-09-26 2003-08-19 University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections
US6380232B1 (en) 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
US7022712B2 (en) 2002-03-26 2006-04-04 Arizona Board Of Regents On Behalf Of The University Of Arizona Solubilization of weak bases
US20120184044A1 (en) * 2008-12-31 2012-07-19 Raptor Detection, Inc. Molecularly-imprinted polymeric materials for visual detection of explosives
RU2668556C1 (en) * 2017-08-07 2018-10-02 Александр Валерьевич Чичварин Fungicide based on fullerene adducts

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3738995A (en) * 1971-05-14 1973-06-12 Du Pont Solvent process for the preparation of 1 - carbamoyl-substituted 2 - benzimidazolecarbamates
DE2340741A1 (en) * 1973-08-11 1975-02-20 Basf Ag FUNGICIDE
US3903297A (en) * 1973-11-01 1975-09-02 Upjohn Co Method of treatment and prophylaxis of gastric hypersecretion and gastric and duodenal ulcers using prostaglandin analogs
DE2952239A1 (en) * 1979-12-22 1981-07-02 Celamerck Gmbh & Co Kg, 6507 Ingelheim FUNGICIDAL MIXTURES
FI68498C (en) * 1981-06-25 1985-10-10 Web Berlin Chemie BLACKING FOR BREAKING OF PHYTOPATOGENIC SWEETS
DE3323024A1 (en) * 1983-06-25 1985-01-03 Hoechst Ag, 6230 Frankfurt METHOD FOR REDUCING BY-PRODUCT SHARES IN THE PRODUCTION OF CARBENDAZIM
GB8521082D0 (en) * 1985-08-22 1985-09-25 Ici Plc Fungicides
GB8629360D0 (en) * 1986-12-09 1987-01-21 Sandoz Ltd Fungicides
US5591744A (en) * 1987-04-16 1997-01-07 Otsuka Pharmaceutical Company, Limited Benzoheterocyclic compounds
US5198444A (en) * 1987-04-17 1993-03-30 Imperial Chemical Industries Plc Methyl α-(2-substituted)pyrid-3-yl-β-methoxyacrylates, compositions containing them and their use as fungicides
HU202728B (en) * 1988-01-14 1991-04-29 Eszakmagyar Vegyimuevek Synergetic fungicide and acaricide compositions containing two or three active components
DE4142731A1 (en) * 1991-12-21 1993-06-24 Hoechst Ag BIOCIDAL POLYMERISATES AND POLYMERISATE DISPERSIONS, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE
DE4242389C2 (en) * 1992-12-08 1995-09-21 Schuelke & Mayr Gmbh Aqueous dispersion with fungicidal and algistatic action
US6177460B1 (en) * 1995-04-12 2001-01-23 The Procter & Gamble Company Method of treatment for cancer or viral infections
US6262093B1 (en) * 1995-04-12 2001-07-17 The Proctor & Gamble Company Methods of treating cancer with benzimidazoles
ZA962879B (en) * 1995-04-12 1997-03-17 Procter & Gamble A pharmaceutical composition for inhibiting the growth of viruses and cancers
NZ305784A (en) * 1995-04-12 2001-03-30 Procter & Gamble Benzimidazole containing medicaments for treating cancers, tumors and viral infections
US5629341A (en) * 1995-04-12 1997-05-13 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US6479526B1 (en) * 1995-04-12 2002-11-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US6265427B1 (en) * 1995-06-07 2001-07-24 The Proctor & Gamble Company Pharmaceutical composition for the method of treating leukemia
GB9725445D0 (en) * 1997-12-01 1998-01-28 Ciba Geigy Ag Organic compounds
PE11499A1 (en) * 1997-05-16 1999-03-01 Procter & Gamble TREATMENT OF HIV AND CANCER
US6506783B1 (en) * 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
US6413973B1 (en) * 1997-12-01 2002-07-02 Syngenta Crop Protection, Inc. Fungicidal combinations comprising quinazolinone
JP4424763B2 (en) * 1998-04-09 2010-03-03 サントリーホールディングス株式会社 Process for producing aromatic compounds by supercritical water treatment
US6245789B1 (en) * 1998-05-19 2001-06-12 The Procter & Gamble Company HIV and viral treatment
DE19842116C2 (en) * 1998-09-07 2001-02-08 Schuelke & Mayr Gmbh Use of derivatives of methylenebisoxazolidine and compositions obtained thereby
NZ514558A (en) * 1999-03-31 2004-02-27 Uaf Technologies And Res Llc Viral treatment
US6136835A (en) * 1999-05-17 2000-10-24 The Procter & Gamble Company Methods of treatment for viral infections
US6197805B1 (en) * 1999-05-27 2001-03-06 Troy Technology Corporation, Inc. Broad spectrum antimicrobial mixtures
US6423734B1 (en) * 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
US6228400B1 (en) * 1999-09-28 2001-05-08 Carlsbad Technology, Inc. Orally administered pharmaceutical formulations of benzimidazole derivatives and the method of preparing the same
US6384049B1 (en) * 2000-05-25 2002-05-07 The Procter & Gamble Company Cancer treatment
US6407105B1 (en) * 2000-09-26 2002-06-18 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6608096B1 (en) * 2000-09-26 2003-08-19 University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections
US6462062B1 (en) * 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6380232B1 (en) * 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
US7022712B2 (en) * 2002-03-26 2006-04-04 Arizona Board Of Regents On Behalf Of The University Of Arizona Solubilization of weak bases

Also Published As

Publication number Publication date
WO2002041891A3 (en) 2003-05-22
US20030149088A1 (en) 2003-08-07
WO2002041891A2 (en) 2002-05-30
US20070043070A1 (en) 2007-02-22

Similar Documents

Publication Publication Date Title
AU2002223827A1 (en) Well treatment
AU2001271043A1 (en) Safe retained needle
AU2001288720A1 (en) Implantable article
AU2001245965A1 (en) Large body stretcher
AU2002231039A1 (en) Therapeutic stockings
AU2002224038A1 (en) Benzimidazole derivatives
AU2001274548A1 (en) Syringe
AU2001280598A1 (en) Anti-occlusion catheter
AU2001242572A1 (en) Nanostructures
AU2001226910A1 (en) Electrolytic treatment
AU2002239395A1 (en) Hiv treatment with benzimidazoles
AU2001236929A1 (en) Surface treatment
AU2001268653A1 (en) Combination hiv therapy including camptothecin
AU2001254561A1 (en) Immunizing against hiv infection
AU2001260236A1 (en) Restricted use syringe
GB0030541D0 (en) Medical uses
AU6904101A (en) Infection model
AU3714800A (en) Hiv therapy
AU2001295815A1 (en) Multiple purpose catheter
AU2001267135A1 (en) Medicaments
AU2000279374A1 (en) Secure syringe
AU2001260045A1 (en) Secure pants
AU2001268677A1 (en) Subtype selective melatonergics
AU2001260789A1 (en) Wheelchair
AU2001266201A1 (en) Medicaments